WHIPPANY, N.J.--(BUSINESS WIRE)-- Bayer today announced that its MEDRAD ® Centargo multi-patient CT injector has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the ...

Dublin, July 26, 2023 (GLOBE NEWSWIRE) -- The "Contrast Media Agent and Injector System Market - A Global and Regional Analysis: Focus on Product and Country Analysis - Analysis and Forecast, ...

Factors such as the growing prevalence of cancer and CVD; a large number of approvals for contrast agents; and increasing investments, funds, and grants by government organizations are driving the ...

New York, Aug. 01, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Contrast Injector Market Research Report by Product, by Application - Global Forecast to 2025 - ...

As per the DBMR Team predictions cited in Contrast Injector Market report, the market will grow with a specific CAGR value in the forecast period of 2021 to 2028. The First Class Contrast Injector ...

Global Contrast Injector Market 2021 Industry Research Report performs comprehensive study about Contrast Injector industry and tells about the market status in the forecast period of 2021 to 2028.

The use of automated contrast injector systems during percutaneous coronary intervention (PCI) does not appear to curb kidney damage compared with manual injection, according to an analysis published ...

Follows recent FDA clearance to expand the use of compatible contrast agent presentations, adding single-dose vials in addition to Imaging Bulk Package presentations Radiology suites now have the ...

Centargo compatible with Ultravist® (iopromide), Isovue® (iopamidol), Optiray® (ioversol), Omnipaque™ (iohexol) and now, Visipaque™ (iodixanol) Follows recent FDA clearance to expand the use of ...